Table 1 Patient’s characteristics (n = 66)
From: Use of continuous glucose monitoring in insulin-treated older adults with type 2 diabetes
Results | |
|---|---|
Gender (female) (n (%)) | 33 (50.0%) |
Age (y/o) (mean ± SD) | 72.5 ± 5.3 |
Educational Level | |
Elementary school | 25 (37.9%) |
Middle school | 11 (16.7%) |
High school | 13 (19.7%) |
College | 17 (25.7%) |
T2DM duration(years)(mean± SD) | 20.0 ± 10.2 |
BMI (kg/m²) (mean ± SD) | 27.8 ± 3.6 |
Obesity (BMI > 30) (n (%)) | 18 (27.3%) |
Body fat (%) (mean ± SD) | 34.1 ± 7.9 |
Visceral fat (%) (mean ± SD) | 12.1 ± 4.1 |
Sarcopenia (n (%)) | 0 (0. %) |
A1C (%) (mean ± SD) | 7.9 ± 0.61 |
ALT (mean ± SD) | 21.4 ± 9.9 |
AST (mean ± SD) | 21.2 ± 5.0 |
Cr (mg/dL) (mean ± SD) | 2.6 ± 12.7 |
eGFR (mean ± SD) | 64.3 ± 16.0 |
Regular exercise, n (%) | 26 (39.4%) |
Diabetes Complications | |
CVD presence, n (%) | 33 (50.0%) |
High Risk CVD*, n (%) | 40 (60.6%) |
Heart Failure, n (%) | 22 (33.3%) |
Retinopathy, n (%) | 12 (18.2%) |
Nephropathy (eGFR < 60), n (%) | 24 (36.4%) |
Neuropathy (n (%), n (%) | 37 (56.1%) |
Public Health System, n (%) | 38 (59,1%) |